Skip to main content
OpenTrials

Clinical trial condition

Agranulocytosis

Explore clinical trials studying Agranulocytosis. Study availability and eligibility vary by location and protocol.

294 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Agranulocytosis trial results

Completed

PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.

NCT03121235

Conditions
Agranulocytosis, Aspergillosis, Aspergillosis, Invasive Pulmonary, +15 more
Locations
  • Academisch Medisch Centrum Amsterdam, Netherlands
  • VU Medisch Centrum Amsterdam, Netherlands
  • Universitair Medisch Centrum Groningen Groningen, Netherlands
  • Leids Universitair Medisch Centrum Leiden, Netherlands
View Trial Details
Completed

SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)

NCT02643420

Conditions
Agranulocytosis, Breast Cancer, Breast Diseases, +11 more
Locations
  • Arizona Center for Cancer Care Glendale, Arizona, United States
  • Arizona Clinical Research Center/ ACRC Tucson, Arizona, United States
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
View all 81 locations
View Trial Details
Completed

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

NCT02953340

Conditions
Agranulocytosis, Breast Cancer, Breast Diseases, +11 more
Locations
  • ACRC/ Arizona Clinical Research Center Inc. Tucson, Arizona, United States
  • Yuma Regional Cancer Center Yuma, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • NEA Baptist Clinic | Fowler Family Center for Cancer Care Jonesboro, Arkansas, United States
View all 74 locations
View Trial Details
Completed

A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

NCT02190721

Conditions
Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations
  • Teva Investigational Site 12958 Long Beach, California, United States
  • Teva Investigational Site 12951 Los Angeles, California, United States
  • Teva Investigational Site 12954 Jackson, Mississippi, United States
  • Teva Investigational Site 12953 Las Vegas, Nevada, United States
View all 33 locations
View Trial Details

Related conditions